PRNewswire

Great Britain is the third major market where donanemab has received approval Donanemab was first approved in the United States in July 2024 and then approved in Japan in September 2024 INDIANAPOLIS, Oct. 23, 2024 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the Medici

HONG KONG, Oct. 23, 2024 /PRNewswire/ — From October 11th to 13th, the “IMPACT2024” global hospitality sector event organized by the School of Hotel and Tourism Management (SHTM) of the Hong Kong Polytechnic University (PolyU) was successfully held at the ICON Hotel in Hong Kong. D

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: